Metraipolis › archive › dc_1cd4945166fd
Pan-RAS Inhibitors: Expanding Therapeutic Potential and Evading Resistance — Europe PMC PMID:42279426
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42279426
- DOI
- 10.3390/cancers18111844
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T17:55:30.692Z
- SHA-256 of the archived text
9727ca9734d1b665b041a14e0aef799125f3e4b7b954850138428a9a02858209- Stable URL of this page
https://metraipolis.com/documento/dc_1cd4945166fd
How to cite
Pan-RAS Inhibitors: Expanding Therapeutic Potential and Evading Resistance — Europe PMC PMID:42279426 — Europe PMC (en), https://europepmc.org/article/MED/42279426 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1cd4945166fd (Metraipolis archive dc_1cd4945166fd, sha256 9727ca9734d1b665b041a14e0aef799125f3e4b7b954850138428a9a02858209)
BibTeX
@misc{dc1cd4945166fd,
title = {Pan-RAS Inhibitors: Expanding Therapeutic Potential and Evading Resistance — Europe PMC PMID:42279426},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42279426},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1cd4945166fd; sha256 9727ca9734d1b665b041a14e0aef799125f3e4b7b954850138428a9a02858209},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279426. Agents can read the archived copy with the MCP tool read_document.